Abbott
Bio-Rad Laboratories
Cepheid
Hologic Inc.
QIAGEN
Roche Diagnostics
Revvity, Inc.
Thermo Fisher Scientific
Ruvos
bioMérieux
Ceres Nanosciences
HDR Inc.
Illumina
Promega
The APHL Corporate Leadership Council (CLC) serves as a valuable link between APHL and the corporate community—each of whom have a shared interest in contributing to the success of public health laboratories. The CLC supports APHL's mission through engagement, informed guidance and the exchange of ideas.
Contact the Corporate Relations team: [email protected]
The CLC provides a platform for corporate members to work with APHL members, Board of Directors, Council of Chairs and federal partners on policy and programmatic initiatives, network and foster business relationships, and bring together traditional and non-traditional voices to advance thought leadership around key public health laboratory issues.
The CLC meets annually and has an active presence at the annual APHL Fall Leadership Meetings. In addition, CLC members participate in various APHL member events and panels throughout the year and provide value-added content to the Industry Matters column in Lab Matters, APHL's quarterly magazine.
The APHL CLC Meeting is one of three gatherings held during the annual three-day APHL Fall Leadership Meetings. The CLC Meeting is an opportunity for industry partners and public health laboratory leaders to meet, network and discuss advances in the field and potential opportunities for the public health laboratory community.
APHL's Diamond and Platinum Level Sustaining Members are invited to participate.
Abbott
Bio-Rad Laboratories
Cepheid
Hologic Inc.
QIAGEN
Roche Diagnostics
Revvity, Inc.
Thermo Fisher Scientific
Ruvos
bioMérieux
Ceres Nanosciences
HDR Inc.
Illumina
Promega